Author Question: Economic deregulation sparked competition among carriers in several areas. Which of these is not an ... (Read 20 times)

lidoalex

  • Hero Member
  • *****
  • Posts: 538
Economic deregulation sparked competition among carriers in several areas. Which of these is not an area of competition?
 a. accessibility
  b. pricing
  c. performance
  d. services

Question 2

Discuss the advantages and disadvantages of secondary data.



huda

  • Sr. Member
  • ****
  • Posts: 304
Answer to Question 1

a

Answer to Question 2

Secondary data are gathered and recorded by someone else prior to (and for purposes other than) the current project. The primary advantage is their availability. It's almost always faster and less expensive than acquiring primary data. Secondary data are essential in instances when data cannot be obtained using primary data collection procedures, such as obtaining information not accessible to a private firm (e.g., taxes paid). An inherent disadvantage is that they were not designed specifically to meet the researchers' need. The most common reasons for this are that the data are outdated, vary in definition of terms, use different units of measurement, and lack the information to verify the data's accuracy. Another disadvantage is that the user has no control over their reliability and validity. Research conducted by others may be biased to support the vested interest of the source.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Medication errors are three times higher among children and infants than with adults.

Did you know?

Colchicine is a highly poisonous alkaloid originally extracted from a type of saffron plant that is used mainly to treat gout.

Did you know?

The first war in which wide-scale use of anesthetics occurred was the Civil War, and 80% of all wounds were in the extremities.

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

Did you know?

According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.

For a complete list of videos, visit our video library